Sphingolipids and lung vascular barrier regulation

Liliana Moreno, Steven M. Dudek, Joe G.N. Garcia

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Long thought to function primarily as the structural components of lipid membranes, sphingolipids are now also recognized as vitally important signaling mediators regulating a diverse range of functions. We recently described the potent vascular barrier-regulating properties of one of these sphingolipids, the lipid and angiogenic factor sphingosine 1-phosphate (S1P) (Garcia et al, 2001). Since disruption of vascular barrier integrity commonly occurs in highly morbid inflammatory lung conditions, a better understanding of the mechanism of barrier regulation would have important clinical implications. In this chapter, we provide a brief overview of vascular barrier regulation before detailing the mechanisms underlying potent barrier-enhancing effects of S1P in vitro and in vivo in models of acute lung injury (ALI) syndromes. The potential ramifications of these findings for the development of specific therapeutic interventions for patients with ALI syndromes are then discussed.

Original languageEnglish (US)
Title of host publicationSphingolipid Biology
PublisherSpringer Japan
Pages403-414
Number of pages12
ISBN (Print)4431341986, 9784431341987
DOIs
StatePublished - Dec 1 2006
Externally publishedYes

    Fingerprint

Keywords

  • acute lung injury
  • cytoskeleton
  • endothelium
  • permeability
  • sphingosine 1-phosphate

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Moreno, L., Dudek, S. M., & Garcia, J. G. N. (2006). Sphingolipids and lung vascular barrier regulation. In Sphingolipid Biology (pp. 403-414). Springer Japan. https://doi.org/10.1007/4-431-34200-1_31